Cited by 3,421Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical TreatmentsIntraperitoneal and Appendiceal Malignancies

The DOI matches its Crossref record; 303 of the 309 references it cites were found in a registry or an index.

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Open access

Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J.H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., Ciardiello, F., D'Hoore, A., Diaz-Rubio, E., Douillard, J.-Y., Ducreux, M., Falcone, A., Grothey, A., Gruenberger, T., Haustermans, K., Heinemann, V., Hoff, P., Köhne, C.-H., Labianca, R., Laurent-Puig, P., Ma, B., Maughan, T., Muro, K., Normanno, N., Österlund, P., Oyen, W.J.G., Papamichael, D., Pentheroudakis, G., Pfeiffer, P., Price, T.J., Punt, C., Ricke, J., Roth, A., Salazar, R., Scheithauer, W., Schmoll, H.J., Tabernero, J., Taïeb, J., Tejpar, S., Wasan, H., Yoshino, T., Zaanan, A., Arnold, D.·2016·Annals of Oncology

DOI 10.1093/annonc/mdw235

Open this paper in CoChat — free account Open PDF

Abstract

Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients with metastatic CRC (mCRC) has improved greatly due not only to an increase in the number of patients being referred for and undergoing surgical resection of their localised metastatic disease but also to a more strategic approach to the delivery of systemic therapy and an expansion in the use of ablative techniques. This reflects the increase in the number of patients that are being managed within a multidisciplinary team environment and specialist cancer centres, and the emergence over the same time period not only of improved imaging techniques but also prognostic and predictive molecular markers. Treatment decisions for patients with mCRC must be evidence-based. Thus, these ESMO consensus guidelines have been developed based on the current available evidence to provide a series of evidence-based recommendations to assist in the treatment and management of patients with mCRC in this rapidly evolving treatment setting.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/annonc/mdw235

Cites

303 of 303 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova‐Foucher, E., Lortet‐Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,243
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Self-citation
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Self-citation
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Van Cutsem, E., Köhne, C.-H., Hitre, E., Zaluski, J., Chang Chien, C.-R., Makhson, A., D'Haens, G., Pintér, T., Lim, R., Bodoky, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805019 · Cited by 3,877
Self-citation
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Self-citation
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer
Fong, Y., Fortner, J. G., Sun, R. L., Brennan, M. F., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199909000-00004 · Cited by 3,722

Show all 309 references

Research works printed but not linked: 6

Stintzing, 2013, Analysis of KRAS/NRAS and BRAF mutations in FIRE-3, Eur J Cancer, 49
Venook, 2014, J Clin Oncol, 32
Collettini, 2012, Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates, Rofo, 184, 316
Lenz, 2014, Ann Oncol, 25
Garcia Alfonso, 2014, Ann Oncol, 25
Cascinu, 2015, Eur J Cancer, 51

Sorted by citations

Items 801–900 of 1,003

Tailored Systemic Therapy for Colorectal Cancer Liver Metastases
Czauderna, C., Luley, K. B., von Bubnoff, N. C. C., & Marquardt, J. U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111780 · Cited by 21
Phase II Study of Third-Line Panitumumab Rechallenge in Patients with Metastatic Wild-Type KRAS Colorectal Cancer Who Obtained Clinical Benefit from First-Line Panitumumab-Based Chemotherapy: JACCRO CC-09
Tsuji, A., Nakamura, M., Watanabe, T., Manaka, D., Matsuoka, H., Kataoka, M., Takeuchi, M., Ichikawa, W., & Fujii, M. (2021) · Targeted Oncology · doi:10.1007/s11523-021-00845-y · Cited by 24
Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy
Liu, Y., Xiao, Q., He, J., Hu, H., Du, J., Zhu, Y., Chen, J., Liu, Z., Wang, J., Sun, L., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02357-6 · Cited by 22
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing
Varughese, L. A., Bhupathiraju, M., Hoffecker, G., Terek, S., Harr, M. H., Hakonarson, H. H., Cambareri, C., Marini, J., Landgraf, J., Chen, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.859846 · Cited by 23
Astragalus mongholicus Bunge and Curcuma aromatica Salisb. inhibits liver metastasis of colon cancer by regulating EMT via the CXCL8/CXCR2 axis and PI3K/AKT/mTOR signaling pathway
Liu, F., Liang, Y., Sun, R., Yang, W., Liang, Z., Gu, J., Zhao, F., & Tang, D. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00641-4 · Cited by 24
A comparison of the simultaneous, liver-first, and colorectal-first strategies for surgical treatment of synchronous colorectal liver metastases at two major liver-surgery institutions in Sweden
Frühling, P., Strömberg, C., Isaksson, B., & Urdzik, J. (2022) · HPB · doi:10.1016/j.hpb.2022.09.001 · Cited by 22
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
Motta, R., Arnao, V. Y., Ballena, S. V. L., Macha, C. A., Lezama, M. S., Román, C. P., Beltran, P. M., & Torrejon, A. F. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1489 · Cited by 23
Use of Contrast Media During CT-guided Thermal Ablation of Colorectal Liver Metastasis for Procedure Planning is Associated with Improved Immediate Outcomes
Paolucci, I., Lin, Y., Jones, A. K., Brock, K. K., & Odisio, B. C. (2023) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-022-03333-6 · Cited by 23
New developments in targeted therapy for metastatic colorectal cancer
Wong, A. H. N., Ma, B. B. Y., & Lui, R. N.-S. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221148540 · Cited by 23
Self-citation
Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies
Kitsel, Y., Cooke, T., Sotirchos, V. S., & Sofocleous, C. T. (2023) · Cancers · doi:10.3390/cancers15061679 · Cited by 24
Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1–BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy
Yue, X., Liu, T., Wang, X., Wu, W., Wen, G., Yi, Y., Wu, J., Wang, Z., Zhan, W., Wu, R., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.017 · Cited by 22
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer
Williams, C. J. M., Elliott, F., Sapanara, N. L., Aghaei, F., Zhang, L., Murányi, A., Yan, D., Bai, I., Zhao, Z., Shires, M., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0859 · Cited by 22
KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies
Ottaiano, A., Sabbatino, F., Perri, F., Cascella, M., Sirica, R., Patrone, R., Capuozzo, M., Savarese, G., Ianniello, M., Petrillo, N., et al. (2023) · Cancers · doi:10.3390/cancers15143579 · Cited by 23
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab
Demurtas, L., Puzzoni, M., Giampieri, R., Ziranu, P., Pusceddu, V., Mandolesi, A., Cremolini, C., Masi, G., Gelsomino, F., Antoniotti, C., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.178 · Cited by 22
Self-citation
Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona
Baraniskin, A., Laethem, J. V., Wyrwicz, L. S., Güller, U., Wasan, H. S., Matysiak‐Budnik, T., Gruenberger, T., Ducreux, M. P., Carneiro, F., Cutsem, E. V., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.09.021 · Cited by 23
Self-citation
Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer
Amadori, M., Barone, D., Scarpi, E., Oboldi, D., Amadori, E., Bandi, G., Rossi, A., Ferroni, F., Ragazzini, A., Gardini, A. C., et al. (2018) · European Radiology · doi:10.1007/s00330-017-5254-5 · Cited by 22
Regorafenib, TAS-102, or fruquintinib for metastatic colorectal cancer: any difference in randomized trials?
Zhang, Q., Wang, Q., Wang, X., Li, J., Shen, L., & Peng, Z. (2019) · International Journal of Colorectal Disease · doi:10.1007/s00384-019-03477-x · Cited by 22
A comprehensive review of economic evaluations of therapeutic drug monitoring interventions for cancer treatments
Vithanachchi, D., Maujean, A., Downes, M., & Scuffham, P. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14494 · Cited by 22
Identification and Characterization of MortaparibPlus—A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by Wild-Type p53-Dependent and -Independent Mechanisms
Sari, A. N., Elwakeel, A., Dhanjal, J. K., Kumar, V., Sundar, D., Kaul, S. C., & Wadhwa, R. (2021) · Cancers · doi:10.3390/cancers13040835 · Cited by 25
A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases
Berardi, G., Chou, J. F., Gönen, M., Balachandran, V. P., Drebin, J. A., Jarnagin, W. R., Kingham, T. P., Soares, K. C., Wei, A. C.-C., & D'Angelica, M. I. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13113-2 · Cited by 21
Risk of Venous Thromboembolism in Patients With Stage III and IV Non–Small-Cell Lung Cancer: Nationwide Descriptive Cohort Study
Ording, A. G., Christensen, T. D., Skjøth, F., Noble, S., Højen, A. A., Mørkved, A. L., Larsen, T. B., Petersen, R. H., Meldgaard, P., Jakobsen, E. H., et al. (2024) · Clinical Lung Cancer · doi:10.1016/j.cllc.2024.04.004 · Cited by 21
Toxicities and management strategies of emerging antibody–drug conjugates in breast cancer
Kang, S., & Kim, S. (2025) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359251324889 · Cited by 24
Prognostic Factors in Colorectal Liver Metastases: An Exhaustive Review of the Literature and Future Prospectives
Conticchio, M., Uldry, É., Hübner, M., Digklia, A., Fraga, M., Sempoux, C. L., Raisaro, J. L., & Fuks, D. (2025) · Cancers · doi:10.3390/cancers17152539 · Cited by 23
The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection
Poston, G. J., Adam, R. A., Xu, J., Byrne, B., Esser, R., Malik, H., Wasan, H. S., & Xu, J. (2017) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2017.07.021 · Cited by 21
Self-citation
Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue
Johnston, L., Power, M., Sloan, P., Long, A. K., Silmon, A., Chaffey, B. T., Lisgo, A. J., Little, L., Vercauteren, E., Steiniche, T., et al. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204629 · Cited by 21
Metastasis directed therapy for liver and lung metastases from colorectal cancer—A population‐based study
Boysen, A. K., Spindler, K. G., Høyer, M., Mortensen, F. V., Christensen, T. D., Farkas, D. K., & Ording, A. G. (2018) · International Journal of Cancer · doi:10.1002/ijc.31626 · Cited by 21
Recent advances in understanding colorectal cancer
Stintzing, S. (2018) · F1000Research · doi:10.12688/f1000research.14604.1 · Cited by 21
Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer
Huemer, F., Schlintl, V., Hecht, S., Hackl, H., Melchardt, T., Rinnerthaler, G., Greil, R., & Weiß, L. (2019) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2019.04.003 · Cited by 22
Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis
Montés, A. F., López, C., Argilés, G., Páez, D., Muñoz, A. M. L., de Paredes, B. G., Abad, D. G., López, C. C., Fonseca, P. J., Gallego-Plazas, J., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0824 · Cited by 21
Electromagnetic navigation system combined with High-Frequency-Jet-Ventilation for CT-guided hepatic ablation of small US-Undetectable and difficult to access lesions
Volpi, S., Tsoumakidou, G., Loriaud, A., Hocquelet, A., Durán, R., & Denys, A. L. (2019) · International Journal of Hyperthermia · doi:10.1080/02656736.2019.1671612 · Cited by 21
Evaluation of a Liquid Biopsy Protocol using Ultra-Deep Massive Parallel Sequencing for Detecting and Quantifying Circulation Tumor DNA in Colorectal Cancer Patients
Nguyen, H. T., Tran, D. H., Ngo, Q. D., Pham, H.-A. T., Tran, T.-T., Tran, V.-U., Pham, T.-V. N., Le, T. K., Le, N. A. T., Nguyen, N. M., et al. (2020) · Cancer Investigation · doi:10.1080/07357907.2020.1713350 · Cited by 21
Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity
Stangl, C., Post, J. B., van Roosmalen, M. J., Hami, N., Verlaan-Klink, I., Vos, H. R., van Es, R. M., Koudijs, M. J., Voest, E. E., Snippert, H. J. G., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0529 · Cited by 21
Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study
Parisi, A., Cortellini, A., Cannita, K., Venditti, O., Camarda, F., Calegari, M. A., Salvatore, L., Tortora, G., Rossini, D., Germani, M. M., et al. (2020) · Cancers · doi:10.3390/cancers12051259 · Cited by 21
The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis
Pereira, P. L., Iezzi, R., Manfredi, R. M., Carchesio, F., Bánsághi, Z., Brountzos, Ε., Spiliοpoulos, S., Echevarría-Uraga, J. J., Gonçalves, B., Inchingolo, R., et al. (2020) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-020-02646-8 · Cited by 21
Self-citation
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS -Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial
Lueong, S., Herbst, A., Liffers, S., Bielefeld, N., Horn, P., Tannapfel, A., Reinacher‐Schick, A., Hinke, A., Hegewisch‐Becker, S., Kolligs, F. T., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa223 · Cited by 21
Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis
Ono, K., Abe, T., Oshita, A., Sumi, Y., Yano, T., Okuda, H., Kurayoshi, M., Kobayashi, T., Ohdan, H., Noriyuki, T., et al. (2021) · World Journal of Surgical Oncology · doi:10.1186/s12957-021-02210-9 · Cited by 20
A Prognostic Nomogram of Colon Cancer With Liver Metastasis: A Study of the US SEER Database and a Chinese Cohort
Liu, C., Hu, C., Huang, J., Xiang, K., Li, Z., Qu, J., Chen, Y., Yang, B., Qu, X., Liu, Y., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.591009 · Cited by 21
Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells
Gloria, H. C., Nogueira, L. J., Grudzinski, P. B., Ghignatti, P. V. D. C., Guecheva, T. N., Leguisamo, N. M., & Saffi, J. (2021) · BMC Cancer · doi:10.1186/s12885-021-08188-7 · Cited by 21
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients
Moretto, R., Rossini, D., Capone, I., Boccaccino, A., Perrone, F., Tamborini, E., Masi, G., Antoniotti, C., Marmorino, F., Conca, V., et al. (2021) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2021.07.001 · Cited by 21
Self-citation
Colorectal Cancer, Liver Metastases and Biotherapies
Osei‐Bordom, D., Kamarajah, S. K., & Christou, N. (2021) · Biomedicines · doi:10.3390/biomedicines9080894 · Cited by 22
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes
Rosa, F., Galiandro, F., Ricci, R., Miceli, D. D., Quero, G., Fiorillo, C., Cina, C., & Alfieri, S. (2021) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-021-02353-z · Cited by 21
Characterization of Anti-Angiogenic Chemo-Sensitization via Longitudinal Ultrasound Localization Microscopy in Colorectal Carcinoma Tumor Xenografts
Lowerison, M. R., Zhang, Y., Chen, X., Fan, T. M., & Song, P. (2021) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2021.3119280 · Cited by 21
Update for Advance CAR-T Therapy in Solid Tumors, Clinical Application in Peritoneal Carcinomatosis From Colorectal Cancer and Future Prospects
Qian, S., Villarejo‐Campos, P., Castellano, I. G., Hernández‐Villafranca, S., García‐Olmo, D., González-Soares, S., Guadalajara, H., Jiménez-Galanes, S., & Qian, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841425 · Cited by 20
Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study
Lehtomäki, K., Stedt, H., Österlund, E., Muhonen, T. T., Soveri, L., Halonen, P., Salminen, T. K., Kononen, J., Kallio, R. S., Ålgars, A., et al. (2022) · Cancers · doi:10.3390/cancers14071713 · Cited by 21
Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer
Cremolini, C., Montagut, C. O., Ronga, P., Venturini, F., Yamaguchi, K., Stintzing, S., & Sobrero, A. F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.946850 · Cited by 22
Self-citation
Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective
Chen, G., Yang, Z., Eshleman, J. R., Netto, G. J., & Lin, M. (2016) · BioMed Research International · doi:10.1155/2016/9850690 · Cited by 23
Adherence and Safety of Regorafenib for Patients with Metastatic Colorectal Cancer: Observational Real-Life Study
Prete, S. D., Cennamo, G., Leo, L., Montella, L., Vincenzi, B., Biglietto, M., Andreozzi, F., Prudente, A., Iodice, P., Savastano, C., et al. (2016) · Future Oncology · doi:10.2217/fon-2016-0421 · Cited by 22
Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status
Thomsen, M., Guren, M. G., Skovlund, E., Glimelius, B. L. G., Hjermstad, M. J., Johansen, J. S., Kure, E. H., Sørbye, H., Pfeiffer, P., Christoffersen, T., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.04.026 · Cited by 21
Self-citation
The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients
Battaglin, F., Schirripa, M., Buggin, F., Pietrantonio, F., Morano, F., Boscolo, G., Tonini, G., Lutrino, E. S., Lucchetti, J., Salvatore, L., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4001-x · Cited by 23
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials
Cremolini, C., Milione, M., Marmorino, F., Morano, F., Zucchelli, G., Mennitto, A., Prisciandaro, M., Lonardi, S., Pellegrinelli, A., Rossini, D., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0015-z · Cited by 20
Self-citation
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases
Loosen, S. H., Tacke, F., Binnebösel, M., Leyh, C., Vucur, M., Heitkamp, F., Schöning, W., Ulmer, T. F., Alizai, P. H., Trautwein, C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25471 · Cited by 21
Clinical update on K-Ras targeted therapy in gastrointestinal cancers
Pant, S., Hubbard, J. M., Martinelli, E., & Bekaii‐Saab, T. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.07.011 · Cited by 21
Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival
Seidensticker, R., Damm, R., Enge, J., Seidensticker, M., Mohnike, K., Pech, M., Hass, P., Amthauer, H., & Ricke, J. (2018) · BMC Cancer · doi:10.1186/s12885-018-4784-9 · Cited by 21
Self-citation
Retrospective study of regorafenib and trifluridine/tipiracil efficacy as a third‑line or later chemotherapy regimen for refractory metastatic colorectal cancer
Tanaka, A., Sadahiro, S., Suzuki, T., Okada, K., Saito, G., & Miyakita, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.9421 · Cited by 22
Spatio-temporal tumor heterogeneity in metastatic CRC tumors: a mutational-based approach
del Carmen, S., Sayagués, J. M., Bengoechea, Ó., Anduaga, M. F., Alcázar, J. A. S., Gervás, R., García, J., Órfão, A., Muñoz‐Bellvís, L., Sarasquete, M. E., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26081 · Cited by 22
Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of the Phase III AIO KRK-0207 Trial
Stintzing, S., Ivanova, B., Ricard, I., Jung, A., Kirchner, T., Tannapfel, A., Juette, H., Hegewisch‐Becker, S., Arnold, D., & Reinacher‐Schick, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00474 · Cited by 23
Self-citation
Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital
Simarro, J., Murria, R., Pérez-Simó, G., Llop, M., Mancheño, N., Ramos, D., de Juan, I., Barragán, E., Laíz, B., Cases, E., et al. (2019) · Cancers · doi:10.3390/cancers11081196 · Cited by 21
Real-World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
Patel, A. K., Barghout, V. E., Yenikomshian, M. A., Germain, G., Jacques, P., Laliberté, F., & Duh, M. S. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0240 · Cited by 21
Immune Cell Infiltration in the Microenvironment of Liver Oligometastasis from Colorectal Cancer: Intratumoural CD8/CD3 Ratio Is a Valuable Prognostic Index for Patients Undergoing Liver Metastasectomy
Peng, J., Wang, Y., Zhang, R., Deng, Y., Xiao, B., Ou, Q., Sui, Q., Xu, J., Qin, J., Lin, J., et al. (2019) · Cancers · doi:10.3390/cancers11121922 · Cited by 21
Early response evaluation during preoperative chemotherapy for colorectal liver metastases: Combined size and morphology‐based criteria predict pathological response and survival after resection
Primavesi, F., Fadinger, N., Biggel, S., Braunwarth, E., Gasser, E., Sprung, S., Göbel, G., Gassner, E.-M., Stättner, S., & Öfner, D. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25796 · Cited by 21
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)
Samalin, E., de la Fouchardière, C., Thézenas, S., Boige, V., Senellart, H., Guimbaud, R., Taı̈eb, J., François, É., Galais, M., Lièvre, A., et al. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.04.008 · Cited by 21
Self-citation
Is It Time to Introduce PET/CT in Colon Cancer Guidelines?
Maffione, A. M., Rubello, D., Caroli, P., Colletti, P. M., & Matteucci, F. (2020) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000003076 · Cited by 21
Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis
Chen, X., Hu, W., Huang, C., Liang, W., Zhang, J., Wu, D., Lv, Z., Li, Y., Luo, Y., Liang, Z., et al. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.06.024 · Cited by 20
Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes
Conci, S., Ruzzenente, A., Pedrazzani, C., Isa, G., Turri, G., Campagnaro, T., Valdegamberi, A., Bagante, F., Marchitelli, I., & Guglielmi, A. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.09.015 · Cited by 21
The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective analysis
Repullo, D., Barbois, S., Léonard, D., Bohlok, A., den Audenaeren, E. T. V., Hendlisz, A., den Eynde, M. V., Donckier, V., Kartheuser, A. H., & Liberale, G. (2021) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2021.01.018 · Cited by 21
Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity
Brisset, M., Mehlen, P., Meurette, O., & Hollande, F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1231416 · Cited by 20
Poria cocos polysaccharides ameliorate AOM/DSS-induced colorectal cancer in mice by remodeling intestinal microbiota composition and enhancing intestinal barrier function
Chen, L., Zhao, S., Chen, Q., Luo, P., Li, X., Song, Y., Pan, S., Wu, Q., Zhang, Y., Shen, X., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144477 · Cited by 20
Primary tumor resection in stage IV unresectable colorectal cancer: what has changed?
Pędziwiatr, M., Mizera, M., Witowski, J. S., Major, P., Torbicz, G., Gajewska, N., & Budzynski, A. Z. (2017) · Medical Oncology · doi:10.1007/s12032-017-1047-6 · Cited by 20
Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials
Abdel-Rahman, O. M., & Karachiwala, H. (2019) · International Journal of Colorectal Disease · doi:10.1007/s00384-019-03389-w · Cited by 20
Characterisation of the Expression of Neurotensin and Its Receptors in Human Colorectal Cancer and Its Clinical Implications
Qiu, S., Nikolaou, S., Zhu, J., Jeffery, P. K., Goldin, R. D., Kinross, J. K., Alexander, J. L., Rasheed, S., Tekkis, P. P., & Kontovounisios, C. (2020) · Biomolecules · doi:10.3390/biom10081145 · Cited by 20
Photothermal therapy technology of metastatic colorectal cancer.
Chen, J., Zeng, Z., Huang, L., Luo, S., Dong, J., Zhou, F. H., Zhou, K., Wang, L., & Kang, L. (2020) · PubMed Central · Cited by 20
Patterns of age disparities in colon and lung cancer survival: a systematic narrative literature review
Pilleron, S., Gower, H., Janssen-Heijnen, M. L. G., Signal, V., Gurney, J., Morris, E. J. A., Cunningham, R., & Sarfati, D. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044239 · Cited by 20
Role of surgical resection and its alternative local therapy for pulmonary metastasis of colorectal cancer
Ogawa, H., Yajima, T., Sohda, M., Shirabe, K., & Saeki, H. (2021) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12472 · Cited by 20
Development and validation of survival nomograms in colorectal cancer patients with synchronous liver metastases underwent simultaneous surgical treatment of primary and metastatic lesions.
Guo, X., Liu, Y., Liu, L., Li, J., Zhao, L., Jin, X., Wei, Y., Lin, B., Shi, S., Li, Z., et al. (2021) · PubMed Central · Cited by 20
Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening?
Arrichiello, G., Poliero, L., Borrelli, C., Paragliola, F., Nacca, V., Napolitano, S., Corte, C. M. D., Martini, G., & Martinelli, E. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100442 · Cited by 20
Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study
Raimondi, A., Fucà, G., Leone, A. G., Lonardi, S., Antoniotti, C., Smiroldo, V., Amatu, A., Tampellini, M., Ritorto, G., Murialdo, R., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100246 · Cited by 21
Diagnostic Value of Delayed PET/MR in Liver Metastasis in Comparison With PET/CT
Zhou, N., Meng, X., Zhang, Y., Yu, B., Yuan, J., Yu, J., Zhu, H., & Yang, Z. C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.717687 · Cited by 20
Comprehensive Analysis of Subtype-Specific Molecular Characteristics of Colon Cancer: Specific Genes, Driver Genes, Signaling Pathways, and Immunotherapy Responses
Hu, F., Wang, J., Zhang, M., Wang, S., Zhao, L., Yang, H., Wu, J., & Cui, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.758776 · Cited by 23
Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver Malignancies
Kovács, A., Bischoff, P., Haddad, H., Zhou, W., Temming, S., Schäfer, A., Spallek, H., Kaupe, L., Kovács, G., & Pinkawa, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030430 · Cited by 20
Combined Estrogen Alpha and Beta Receptor Expression Has a Prognostic Significance for Colorectal Cancer Patients
Topi, G., Ghatak, S., Satapathy, S. R., Ehrnström, R. A., Lydrup, M., & Sjölander, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.739620 · Cited by 21
The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients
Domper-Arnal, M. J., Hijos, G., & Lanas, Á. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221117636 · Cited by 23
The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis
Zhao, N., Xu, H., Zhou, D., Xu, X., Ge, W., & Cao, D. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-683 · Cited by 21
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)
Argilés, G., Mulet-Margalef, N., Valladares‐Ayerbes, M., Viéitez, J. M., Grávalos, C., Alfonso, P. G., Santos, C., Tobeña, M., García-Paredes, B., Benavides, M., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.09.037 · Cited by 20
Self-citation
Distinct Molecular Profiles of Sporadic Early-Onset Colorectal Cancer: A Population-Based Cohort and Systematic Review
Hamilton, A. C., Bannon, F. J., Dunne, P. D., James, J. A., McQuaid, S., Gray, R. T., Salto‐Tellez, M., Cardwell, C. R., Loughrey, M. B., & Coleman, H. G. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.11.005 · Cited by 23
Deep learning model based on contrast-enhanced ultrasound for predicting early recurrence after thermal ablation of colorectal cancer liver metastasis
Zhao, Q., He, X., Wang, K., Cheng, Z., Han, Z., Liu, F., Yu, X., Zhong, H., Yu, J., An, C., et al. (2022) · European Radiology · doi:10.1007/s00330-022-09203-6 · Cited by 20
Activation of cGAS-STING Pathway Is Associated with MSI-H Stage IV Colorectal Cancer
Kunac, N., Degoricija, M., Viculin, J., Omerović, J., Terzić, J., Vilović, K., & Korać-Prlić, J. (2022) · Cancers · doi:10.3390/cancers15010221 · Cited by 21
Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer
Chidimatsu, H., Tsunedomi, R., Nakagami, Y., Xu, M. Q., Nakajima, M., Nakashima-Nakasuga, C., Tomochika, S., Yoshida, S., Suzuki, N., Watanabe, Y., et al. (2022) · Anticancer Research · doi:10.21873/anticanres.16139 · Cited by 20
Combined ablation and resection (CARe) for resectable colorectal cancer liver Metastases-A propensity score matching study
Liu, M., Wang, Y., Wang, K., Bao, Q., Wang, H., Jin, K., Liu, W., Yan, X., & Xing, B. (2023) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2023.05.006 · Cited by 20
TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer
Gou, H., Wong, C. C., Chen, H., Shang, H., Su, H., Zhai, J., Liu, W., Liu, W., Sun, D., Wang, X., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216438 · Cited by 20
Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer
Bajpai, P., Agarwal, S. D., Afaq, F., Diffalha, S. A., Chandrashekar, D. S., Kim, H., Shelton, A., Miller, C. R., Singh, S. K., Singh, R., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03106-8 · Cited by 20
SLC14A1 and TGF-β signaling: a feedback loop driving EMT and colorectal cancer metachronous liver metastasis
Zhang, Y., Yang, Y., Qi, X., Cui, P., Kang, Y., Liu, H., Wei, Z., & Wang, H. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03114-8 · Cited by 21
Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded)
de Baère, T., Tselikas, L., Boige, V., Ducreux, M. P., Malka, D., Goèré, D., Benahim, E., & Deschamps, F. (2016) · Bulletin du Cancer · doi:10.1016/j.bulcan.2016.10.025 · Cited by 20
Self-citation
Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
Solaini, L., D’Acapito, F., Passardi, A., Framarini, M., Tauceri, F., Pietrantonio, D. D., Frassineti, G. L., Gardini, A. C., Cucchetti, A., Cavaliere, D., et al. (2019) · World Journal of Surgical Oncology · doi:10.1186/s12957-019-1602-z · Cited by 20
Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases
Brunsell, T. H., Cengija, V., Sveen, A., Bjørnbeth, B. A., Røsok, B. I., Brudvik, K. W., Guren, M. G., Lothe, R. A., Abildgaard, A., & Nesbakken, A. (2019) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2019.07.017 · Cited by 20
Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells In vitro
Freund, E., Liedtke, K. R., Miebach, L., Wende, K., Heidecke, A., Kaushik, N. K., Choi, E. H., Partecke, L.-I., & Bekeschus, S. (2020) · Cancers · doi:10.3390/cancers12010122 · Cited by 21
Can Dual-energy CT-based Virtual Monoenergetic Imaging Improve the Assessment of Hypodense Liver Metastases in Patients With Hepatic Steatosis?
Lenga, L., Lange, M., Arendt, C. T., Yel, İ., Booz, C., Durden, J., Leithner, D., Vogl, T. J., Albrecht, M. H., & Martin, S. S. (2020) · Academic Radiology · doi:10.1016/j.acra.2020.03.044 · Cited by 20
A Novel Prognostic Model and Practical Nomogram for Predicting the Outcomes of Colorectal Cancer: Based on Tumor Biomarkers and Log Odds of Positive Lymph Node Scheme
Zhu, J. W., Hao, J., Ma, Q., Shi, T., Wang, S., Yan, J., Chen, R., Xu, D., Jiang, Y., Zhang, J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.661040 · Cited by 20
SOULMATE: the Swedish study of liver transplantation for isolated colorectal cancer liver metastases not suitable for operation or ablation, compared to best established treatment—a randomized controlled multicenter trial
Reivell, V., Hagman, H., Haux, J., Jorns, C., Lindnér, P., & Taflin, H. A. (2022) · Trials · doi:10.1186/s13063-022-06778-9 · Cited by 20
High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab
Kumar, S. S., Tomita, Y., Wrin, J., Bruhn, M. A., Swalling, A., Mohammed, M., Price, T. J., & Hardingham, J. E. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1596-8 · Cited by 20
Self-citation
Increased immune cell infiltration in patient-derived tumor explants treated with Traniplatin: an original Pt( iv ) pro-drug based on Cisplatin and Tranilast
Re, D. L., Montagner, D., Tolan, D. A., Sanza, C. D., Iglesias, M., Calon, A., & Giralt, E. (2018) · Chemical Communications · doi:10.1039/c8cc02071j · Cited by 20

Authors: Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., Ciardiello, F., D'Hoore, A., Diaz-Rubio, E., Douillard, J.-Y., Ducreux, M., Falcone, A., Grothey, A., Gruenberger, T., Haustermans, K., Heinemann, V., Hoff, P., Köhne, C.-H., Labianca, R., Laurent-Puig, P., Ma, B., Maughan, T., Muro, K., Normanno, N., Österlund, P., Oyen, W. J. G., Papamichael, D., Pentheroudakis, G., Pfeiffer, P., Price, T. J., Punt, C., Ricke, J., Roth, A., Salazar, R., Scheithauer, W., Schmoll, H. J., Tabernero, J., Taïeb, J., Tejpar, S., Wasan, H., Yoshino, T., Zaanan, A., & Arnold, D.
Affiliations: Universitat de València (ES)
Hôpital Paul-Brousse (FR)
Ospedale Policlinico San Martino (IT)
Tel Aviv University (IL)
University of Turin (IT)
Northwestern Medicine (US)
Unified Szent István and Szent László Hospital (HU)
University of Campania "Luigi Vanvitelli" (IT)
Institut de Cancérologie de l'Ouest (FR)
Université Paris-Saclay (FR)
University of Pisa (IT)
Mayo Clinic (US)
Krankenanstalt Rudolfstiftung der Stadt Wien (AT)
KU Leuven (BE)
Ludwig-Maximilians-Universität München (DE)
Universidade de São Paulo (BR)
Klinikum Oldenburg (DE)
Ospedale Papa Giovanni XXIII (IT)
Chinese University of Hong Kong (HK)
University of Oxford (GB)
Aichi Cancer Center (JP)
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
Institute of Cancer Research (GB)
Bank of Cyprus Oncology Center (CY)
University of Ioannina (GR)
Odense University Hospital (DK)
Queen Elizabeth Hospital (AU)
Amsterdam UMC Location University of Amsterdam (NL)
University Hospital Magdeburg (DE)
University Hospital of Geneva (CH)
Institut Català d'Oncologia (ES)
Comprehensive Cancer Center Vienna (AT)
Martin Luther University Halle-Wittenberg (DE)
Vall d'Hebron Hospital Universitari (ES)
Universitair Ziekenhuis Leuven (BE)
Imperial College Healthcare NHS Trust (GB)
National Cancer Center Hospital East (JP)
Hôpital Européen Georges-Pompidou (FR)
ORCID: Cervantes, A.
Adam, R.
Sobrero, A.
Bardelli, A.
Benson, A.
Bodoky, G.
Ciardiello, F.
Douillard, J.-Y.
Ducreux, M.
Falcone, A.
Grothey, A.
Gruenberger, T.
Haustermans, K.
Heinemann, V.
Hoff, P.
Labianca, R.
Ma, B.
Maughan, T.
Muro, K.
Normanno, N.
Oyen, W.J.G.
Papamichael, D.
Pentheroudakis, G.
Pfeiffer, P.
Price, T.J.
Punt, C.
Ricke, J.
Salazar, R.
Schmoll, H.J.
Tabernero, J.
Tejpar, S.
Wasan, H.
Yoshino, T.
Zaanan, A.
Arnold, D.
Venue: Annals of Oncology
Publisher: Elsevier BV
Published: 2016-08
Volume: 27
Issue: 8
Pages: 1386-1422
ISSN: 0923-7534 (ISSN-L)
DOI: 10.1093/annonc/mdw235
OpenAlex: W2470575266
Cited by: 3,421
References: 309
Citations by year: 2026: 199 · 2025: 236 · 2024: 297 · 2023: 364 · 2022: 481 · 2021: 518 · 2020: 444 · 2019: 365 · 2018: 279 · 2017: 189 · 2016: 39
FWCI: 155.89
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1191 d)
Locations: Annals of Oncology (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
Data Archiving and Networked Services (DANS) (submittedVersion)
CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
Lirias (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Radboud Repository (Radboud University) (submittedVersion)
RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
Funders: Cancer Research UK (13363)
National Institute for Health and Care Research (11/100/50)
Topics: Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
Keywords: metastatic colorectal cancer, colorectal cancer, surgical resection of metastases, systemic therapy, multidisciplinary management, treatment decision-making, evidence-based recommendations
MeSH terms: Humans, Neoplasm Metastasis, Prognosis, Biomarkers, Tumor, Colorectal Neoplasms, Guidelines as Topic, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks